Showing results (511-520 of 688) with videos related to

Sort By:
Pageof 69
The Journal of Rheumatology|November 17, 2017
Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III StudiesChristina Charles-Schoeman, Désirée van der Heijde, Gerd R Burmester, et al.
The Journal of Rheumatology|November 15, 2022
Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV TrialFilip Van den Bosch, James Cheng-Chung Wei, Peter Nash, et al.
Arthritis Research & Therapy|October 31, 2018
Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of diseasePhilip Helliwell, Laura C Coates, Oliver FitzGerald, et al.
ACS Applied Materials & Interfaces|February 16, 2026
Selective Serine Substitutions of Antimicrobial Peptides Reveal Different Mechanistic Actions Toward Gram-Negative BacteriaAnna Stephens, Tianhao Ge, Ke Ding, et al.
The Journal of Rheumatology|May 17, 2013
Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: results through 2 years of the GO-FORWARD study extensionEdward C Keystone, Mark C Genovese, Stephen Hall, et al.
JAMA|May 22, 2024
Krill Oil for Knee Osteoarthritis: A Randomized Clinical TrialLaura L Laslett, Lieke E J M Scheepers, Benny Antony, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 24, 2018
Are the metabolic benefits of resistance training in type 2 diabetes linked to improvements in adipose tissue microvascular blood flow?Donghua Hu, Ryan D Russell, Devika Remash, et al.
Rheumatology (Oxford, England)|December 5, 2021
Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritisPeter Nash, Pascal Richette, Laure Gossec, et al.
RMD Open|March 26, 2024
Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled studyLaura C Coates, Laure Gossec, Miriam Zimmermann, et al.
Trials|September 11, 2022
Study protocol for a randomised controlled trial of diacerein versus placebo to treat knee osteoarthritis with effusion-synovitis (DICKENS)Guoqi Cai, Graeme Jones, Flavia M Cicuttini, et al.
Pageof 69